Table 5.
Daily intake (g/day) of olive oil (OO) and risk of SGA for entire sample and stratified on degree of SGA.
| OO Daily Intake (g/day) | Cases n (%) | Controls n (%) | cOR (95% CI) | aOR (95% CI) |
|---|---|---|---|---|
| All SGA | ||||
| <5 | 71 (13.7) | 42 (8.1) | 1 (reference) | 1 (reference) |
| 5–9.9 | 60 (11.6) | 70 (13.5) | 0.48 (0.28–0.82) * | 0.52 (0.29–0.93) * |
| 10–19.9 | 150 (29.0) | 159 (30.7) | 0.53 (0.34–0.85) * | 0.55 (0.33–0.89) * |
| 20–29.9 | 149 (28.8) | 170 (32.8) | 0.49 (0.31–0.78) * | 0.49 (0.30–0.81) * |
| ≥30 | 88 (17.0) | 77 (14.9) | 0.64 (0.39–1.06) | 0.61 (0.51–1.05) |
| p for trend | 0.735 | 0.961 | ||
| <5 vs. ≥5 | 0.53 (0.35–0.81) * | 0.53 (0.34–0.85) * | ||
| Moderate SGA Percentiles 6–10 | ||||
| <5 | 45 (13.9) | 26 (8.1) | 1 (reference) | 1 (reference) |
| 5–9.9 | 42 (13.0) | 47 (14.5) | 0.48 (0.25–0.94) * | 0.55 (0.26–1.16) |
| 10–19.9 | 103 (31.9) | 95 (29.4) | 0.60 (0.34–1.07) | 0.59 (0.31–1.12) |
| 20–29.9 | 85 (26.3) | 114 (35.0) | 0.41 (0.23–0.74) * | 0.41 (0.21–0.78) * |
| ≥30 | 48 (14.9) | 42 (13.0) | 0.64 (0.34–1.22) | 0.62 (0.31–1.25) |
| p for trend | 0.964 | 0.868 | ||
| <5 vs. ≥5 | 0.53 (0.31–0.89) * | 0.53 (0.30–0.96) * | ||
| Severe SGA, Percentiles ≤5 | ||||
| <5 | 26 (13.3) | 16 (8.2) | 1 (reference) | 1 (reference) |
| 5–9.9 | 18 (9.2) | 23 (11.8) | 0.47 (0.19–1.16) | 0.46 (0.17–1.22) |
| 10–19.9 | 47 (24.1) | 64 (32.8) | 0.44 (0.20–0.94) * | 0.44 (0.19–0.99) * |
| 20–29.9 | 64 (32.8) | 57 (29.2) | 0.68 (0.32–1.46) | 0.61 (0.26–1.34) |
| ≥30 | 40 (20.5) | 35 (18.0) | 0.66 (0.29–1.50) | 0.59 (0.24–1.44) |
| p for trend | 0.568 | 0.853 | ||
| <5 vs. ≥5 | 0.55 (0.27–1.10) | 0.51 (0.24–1.07) | ||
aOR: Adjusted odds ratio by income, smoking, previous preterm/low birthweight newborn, energy intake, newborn’s gender, and pre-pregnancy BMI; cOR: Crude odds ratio and confidence intervals (95% CI); * Significant association.